Clinical Trial

Cognitive-Sensorimotor Function in Long-COVID

Recruiting
View on ClinicalTrials.gov →
Summary
Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculoskeletal impairment that can affect gait and balance. Identifying the factors contributing to these impairments and how they influence functional mobility is the first step towards creating effective evaluation and treatment protocols. In this study the investigators will examine cognition, vision, proprioception, muscle strength, gait and balance in persons with and without PASC to understand how PASC may impact functional mobility through a cognitive-sensorimotor lens. Gait and balance will be studied in environments that stress cognitive and sensory abilities. Study outcomes will be critical for the development of evidence-based Veteran Health Administration diagnostic and standard-of-care protocols to address gait and balance dysfunction in Veterans with PASC for restoring their functional mobility and independence.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-15
Trial Details
NCT Number NCT06850350
Lead Sponsor VA Office of Research and Development
Collaborators: Edward Hines Jr. VA Hospital
Conditions Post-acute Sequelae of SARS-CoV-2 Infection
Enrollment 136 participants
Start Date 2026-04-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-08